NCT06607185 2026-04-22A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsEli Lilly and CompanyPhase 1 Active not recruiting750 enrolled
NCT05564377 2026-04-21Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialNational Cancer Institute (NCI)Phase 2 Recruiting2,900 enrolled
NCT05919264 2026-04-09FOG-001 in Locally Advanced or Metastatic Solid TumorsParabilis Medicines, Inc.Phase 1/2 Recruiting595 enrolled